|
Volumn 20, Issue 17, 2001, Pages 2101-2111
|
Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation
a b a c d a |
Author keywords
Breast cancer; c erbB2 (neu); Gastric cancer; HER2; HER2 ECD; Ribozyme
|
Indexed keywords
COMPLEMENTARY DNA;
DOXORUBICIN;
EPIDERMAL GROWTH FACTOR;
MESSENGER RNA;
MITOGEN ACTIVATED PROTEIN KINASE;
NEU DIFFERENTIATION FACTOR;
RIBOZYME;
ADENOCARCINOMA;
ARTICLE;
BREAST CANCER;
CELL PROLIFERATION;
CONTROLLED STUDY;
ENZYME ACTIVATION;
GENE OVEREXPRESSION;
HUMAN;
HUMAN CELL;
NUCLEOTIDE SEQUENCE;
ONCOGENE NEU;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
STOMACH CANCER;
TUMOR CELL;
ALTERNATIVE SPLICING;
BASE SEQUENCE;
BREAST NEOPLASMS;
CELL DIVISION;
DNA, COMPLEMENTARY;
DOWN-REGULATION;
DOXYCYCLINE;
EPIDERMAL GROWTH FACTOR;
GENES, ERBB-2;
GROWTH INHIBITORS;
HUMANS;
MAP KINASE SIGNALING SYSTEM;
MITOGEN-ACTIVATED PROTEIN KINASE 1;
MITOGEN-ACTIVATED PROTEIN KINASE 3;
MITOGEN-ACTIVATED PROTEIN KINASES;
MOLECULAR SEQUENCE DATA;
NEUREGULIN-1;
PROTEIN STRUCTURE, TERTIARY;
RECEPTOR, ERBB-2;
RNA, CATALYTIC;
RNA, MESSENGER;
STOMACH NEOPLASMS;
TRANSFECTION;
TUMOR CELLS, CULTURED;
|
EID: 0035912086
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1204305 Document Type: Article |
Times cited : (53)
|
References (30)
|